Trial reportBMC pediatrics2026
Clinical study on improving lung function in children after Mycoplasma pneumoniae pneumonia (MMP) via traditional Chinese medicine meridian massage.
Trial report in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundPneumonia impairs lung development, structure, and function during children’s critical growth stages. Traditional Chinese Medicine (TCM) boosts constitution, yet the efficacy of TCM meridian massage for post-pneumonia lung function improvement remains unclear. This study investigates its role as an adjuvant therapy for lung function recovery in post-discharge children with Mycoplasma pneumoniae pneumonia (MMP).
methodsSixty-four MMP children with abnormal lung function at discharge (Jan 2023–Dec 2024) were randomized to treatment (n = 32) or control (n = 32) groups. The treatment group received meridian massage (3 sessions/week for 1 month) with three acupoint categories: lung-ventilating/cough-relieving (Feishu BL13, Danzhong CV17), phlegm-resolving (Tiantu CV22, Fenglong ST40), and spleen-lung-nourishing (Zusanli ST36, Pishu BL20). The control group only underwent lung function re-evaluation 1 month post-discharge. Data were analyzed via Prism® 10.0.
resultsTwenty-five treatment and 31 control patients completed follow-up finally. Baseline mixed-type lung function abnormalities and key parameters (e.g., FVC, FEV1) were comparable (p ≥ 0.05). At 1month post-discharge, recovery rates were 88.8% (22/25) vs. 41.9% (13/31) in the two groups, respectively. The treatment group showed superior improvements in large (FVC, FEV1, PEF) and small (MEF25, MEF50, MEF75, MMEF) airway parameters (p < 0.05), with no difference in FEV1/FVC (p > 0.05).
conclusionsMeridian massage safely and effectively promotes lung function recovery in post-MMP children through anti-inflammatory immune modulation and meridian-zang-fu regulation. It provides a novel therapeutic option for post-pneumonia lung dysfunction and evidence-based support for preventing long-term pulmonary sequelae.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.